Saturday, April 30, 2016

Association Between Accelerated Multimorbidity and Age-Related Cognitive Decline in Older Baltimore Longitudinal Study of Aging Participants without Dementia - American Geriatric Society

Objectives

To explore the association between rate of physical health deterioration, operationalized as rising multimorbidity overtime, and longitudinal decline in cognitive function in older adults without dementia.

Design

Longitudinal (Baltimore Longitudinal Study of Aging (BLSA)).

Setting

Community.

Participants

BLSA participants aged 65 and older followed for an average of 3 years and free of dementia or mild cognitive impairment (MCI) at baseline and follow-up (N = 756).

Measurements

Standardized neurocognitive tests evaluating mental status, memory, executive function, processing speed, and verbal fluency were administered. Multimorbidity was assessed at each visit as number of diagnosed chronic diseases from a predefined list. Faster accumulation of chronic diseases was defined as upper quartile of rate of change in number of diseases over time (≥0.25 diseases/year).

Results

Faster accumulation of chronic diseases was significantly associated with greater rate of decline on the Category (P = .01) and Letter (P = .01) Fluency Tests. Similar trends were also found for the Trail-Making Test Parts A (P = .08) and B (P = .07); no association was found with rate of change in visual and verbal memory.

Conclusion

Although further investigations are required to validate the results and fully understand the underlying mechanisms, these findings suggest that accelerated deterioration of physical health is associated with accelerated decline with aging in specific cognitive domains in older adults without dementia.



from Journal of the American Geriatrics Society http://ift.tt/24rPjXg
via IFTTT

Effect of Ownership on Hospice Service Use: 2005–2011 - American Geriatric Society

Objectives

To assess differences in populations and service use according to hospice ownership, chain status, and agency size.

Design

Retrospective cohort study.

Setting

United States.

Participants

Medicare beneficiaries aged 65 and older enrolled in hospice during 2005 to 2011 N = 5,405,526).

Measurements

Hospice use according to ownership category (for-profit nonchain and chain, not-for-profit nonchain and chain, government) and agency size (0–50, 51–200, 201–400, ≥401 individuals discharged each year). Mean length of use, stays of 3 days or fewer, stays ending with live discharge, and decedents receiving no general inpatient care (GIP)- or continuous home care (CHC)-level hospice in the last 7 days of life.

Results

After adjusting for individual and geographic differences, for-profit nonchain and chain agencies had longer mean length of use (84.5 and 91.2 days, respectively) than other agency types (66.3–72.5 days), higher rates of live discharge (21.0% and 20.2% vs 14.6–15.9%), and lower proportions of stays of 3 days or fewer (13.9% and 14.7% vs 16.6–17.5%) (all P < .001). The proportion of decedents not receiving GIP- or CHC-level care before death was highest in for-profit chains (75.9%) and lowest in not-for-profit nonchains (63.2%). Smaller agencies had longer mean length of use, higher live discharge rates, lower rates of stays of 3 days or fewer, and higher rates of individuals receiving no GIP- or CHC-level care. There were considerable differences in patient traits and unadjusted service use between the nation's largest chains.

Conclusion

In addition to for-profit and not-for-profit hospice agencies differing according to important dimensions, there is substantial heterogeneity within these ownership categories, highlighting the need to consider factors such as agency size and chain affiliation in understanding variations in Medicare beneficiaries’ hospice care.



from Journal of the American Geriatrics Society http://ift.tt/1UnLRKp
via IFTTT

Drug Utilization and Inappropriate Prescribing in Centenarians - American Geriatric Society

Objectives

To use primary care electronic health records (EHRs) to evaluate prescriptions and inappropriate prescribing in men and women at age 100.

Design

Population-based cohort study.

Setting

Primary care database in the United Kingdom, 1990 to 2013.

Participants

Individuals reaching the age of 100 between 1990 and 2013 (N = 11,084; n = 8,982 women, n = 2,102 men).

Measurements

Main drug classes prescribed and potentially inappropriate prescribing according to the 2012 American Geriatrics Society Beers Criteria.

Results

At the age of 100, 73% of individuals (79% of women, 54% of men) had received one or more prescription drugs, with a median of 7 (interquartile range 0–12) prescription items. The most frequently prescribed drug classes were cardiovascular (53%), central nervous system (CNS) (53%), and gastrointestinal (47%). Overall, 32% of participants (28% of men, 32% of women) who received drug prescriptions may have received one or more potentially inappropriate prescriptions, with temazepam and amitriptyline being the most frequent. CNS prescriptions were potentially inappropriate in 23% of individuals, and anticholinergic prescriptions were potentially inappropriate in 18% of individuals.

Conclusion

The majority of centenarians are prescribed one or more drug therapies, and the prescription may be inappropriate for up to one-third of these individuals. Research using EHRs offers opportunities to understand prescribing trends and improve pharmacological care of the oldest adults.



from Journal of the American Geriatrics Society http://ift.tt/24rPn9m
via IFTTT

Comparing Prognostic Tools for Cancer Screening: Considerations for Clinical Practice and Performance Assessment - American Geriatric Society

Objectives

To compare the agreement and rates of cancer screening using four prognostic tools that require different types of clinical information.

Design

Observational retrospective cohort study.

Setting

2009 and 2010 waves of the Medicare Current Beneficiary Survey.

Participants

Adults aged 66–90 with survey and claims data (N = 9,469).

Measurements

Agreement between four indices predicting short-term (4–5 years) and long-term (9–10 years) survival; self-reported breast and prostate cancer screening.

Results

Agreement between the four prognostic tools was high. Pearson correlation coefficients ranged from 0.63 to 0.90 for short-term survival and 0.68 to 0.94 for long-term survival. When defining limited short-term life expectancy as less than 25% chance of surviving 4 or 5 years, all four tools agreed in 96.4% of the sample. All four tools agreed in their placement of participants into limited or not-limited long-term life expectancy in 77.1% of participants (<25% chance of surviving 9 or 10 years). Rates of cancer screening were similarly high in individuals with limited long-term life expectancy regardless of the tool used: greater than 31% for mammographic screening in women and greater than 69% for prostate cancer screening.

Conclusion

There is substantial agreement among different prognostic tools for short- and long-term survival in Medicare beneficiaries. The high rates of cancer screening of individuals with limited life expectancy suggest the importance of incorporating tools into clinical decision-making.



from Journal of the American Geriatrics Society http://ift.tt/1UnLRKj
via IFTTT

Serum of 25-Hydroxyvitamin D and Intact Parathyroid Hormone Levels in Postmenopausal Women with Hip and Upper Limb Fractures - American Geriatric Society

Objectives

To assess the serum of 25-hydroxyvitamin D (25(OH)D) and intact parathyroid hormone (iPTH) levels in postmenopausal women from northern China with hip and upper limb fractures.

Design

Case–control.

Setting

Affiliated Hospital of Qingdao University.

Participants

Postmenopausal women diagnosed with hip fracture (n = 335) and matched controls without fracture (n = 335).

Measurements

Between 2011 and 2013, fasting venous samples were analyzed for 25(OH)D, iPTH, alkaline phosphatase (ALP), calcium, and phosphorus. All women completed a standardized questionnaire designed to document putative risk factors for fractures.

Results

Eight percent of participants had vitamin D deficiency, and 66.0% had secondary hyperparathyroidism. Serum 25(OH)D levels were significantly (P < .001) lower in women with hip fracture than in controls. Multivariate logistic regression analysis adjusted for common risk factors showed that serum 25(OH)D of 20 ng/mL or less was an independent indicator of hip fracture (odds ratio (OR) = 2.98, 95% confidence interval (CI) = 2.11–4.20) and concomitant upper limb fracture in those with existing hip fractures (OR = 4.77, 95% CI = 1.60–10.12). The area under the receiver operating characteristic curve of 25(OH)D was 0.77 (95% CI = 0.68–0.84) for hip fracture and 0.80 (95% CI = 0.72–0.89) for hip and upper limb fractures.

Conclusion

Vitamin D insufficiency and secondary hyperparathyroidism were a common problem in postmenopausal women who presented with concomitant hip and upper limb fractures, suggesting that they might contribute to the pathophysiology of fractures in postmenopausal women.



from Journal of the American Geriatrics Society http://ift.tt/24rPmT4
via IFTTT

Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies - American Geriatric Society

Objectives

To examine the relationship between herpesvirus infections and mortality and incident frailty risks in community-dwelling older women.

Design

Nested prospective cohort study.

Setting

Women's Health and Aging Studies I and II.

Participants

Community-dwelling older women aged 70 to 79 (n = 633).

Measurements

Baseline serum antibody (immunoglobulin G) levels against four herpesviruses (herpes simplex virus types 1 (HSV-1) and 2 (HSV-2), varicella-zoster virus (VZV), 7 Epstein-Barr virus (EBV)), 3-year incident frailty rates, and 5-year mortality.

Results

Women seropositive for HSV-1 and HSV-2, but not VZV and EBV, had higher risk of 3-year incident frailty (HSV-1: hazard ratio (HR) = 1.90, 95% confidence interval (CI) = 0.96–3.74; HSV-2: HR = 2.10, 95% CI = 1.05–4.37) and 5-year mortality (HR = 1.73, 95% CI = 0.93–3.20; HR = 1.80, 95% CI = 0.94–3.44, respectively) than seronegative women. Incremental increases in serum HSV-1 and HSV-2 antibody levels were associated with incrementally higher risks of incident frailty and mortality. After adjustment for potential confounders, only higher serum HSV-2 antibody level was independently predictive of higher risk of mortality in older women (for each unit increase in antibody index, HR = 1.47, 95% CI = 1.05–2.07).

Conclusion

HSV-1 and HSV-2 antibody levels are not independently associated with risk of incident frailty in older women. Only HSV-2 antibody level is independently predictive of 5-year mortality risk, with each incremental increase in the antibody level adding further risk.



from Journal of the American Geriatrics Society http://ift.tt/1UnLRtX
via IFTTT

The Republic of Tea Issues Voluntary Recall of Organic Turmeric Ginger Green Tea - FDA Safety Alerts & Drug Recalls

The Republic of Tea is dedicated to the health and wellness of each and every citizen (customer). As such, we are issuing a voluntary recall of our Organic Turmeric Ginger Green Tea in response to a possible health risk.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1WZuMXV
via IFTTT

Friday, April 29, 2016

Making It A Lifestyle, L.L.C. Issues a Voluntary Nationwide Recall of 3rd Degree, Black Gold X Advanced, and Black Label X Due to the Presence of Undeclared Sibutramine and Sildenafil - FDA Safety Alerts & Drug Recalls

Making It A Lifestyle, L.L.C. is voluntarily recalling all lots of 3rd Degree, Black Gold X Advanced and Black Label X capsule form supplements to the consumer level. The products have been found to contain undeclared sibutramine and sildenafil.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1SV6jDa
via IFTTT

Federal judge enters order of permanent injunction against Paul W. Franck - FDA Press Releases

The U.S. Food and Drug Administration today announced that U.S. District Judge Carlos E. Mendoza entered an order of permanent injunction against Paul W. Franck of Ocala, Florida. According to the complaint filed with the consent decree, Franck manufactured and distributed drug products that were adulterated and misbranded in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The U.S. Department of Justice brought the action on behalf of the FDA.

from Food and Drug Administration--Press Releases http://ift.tt/1O1hEtY
via IFTTT

FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease - FDA Press Releases

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.

from Food and Drug Administration--Press Releases http://ift.tt/1rojKPM
via IFTTT

7-Eleven Issues Allergy Alert on Undeclared Peanut in Fresh Fully Baked Chocolate Chunk, Sugar and Oatmeal Raisin Cookies - FDA Safety Alerts & Drug Recalls

7-Eleven, Inc. of Irving, TX is recalling fully baked chocolate chunk, sugar and oatmeal raisin cookies produced by CSM Bakery Solutions frozen cookie pucks because they may contain undeclared peanut. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/26C4wHf
via IFTTT

Federal judge enters order of permanent injunction against Paul W. Franck - FDA Press Releases

The U.S. Food and Drug Administration today announced that U.S. District Judge Carlos E. Mendoza entered an order of permanent injunction against Paul W. Franck of Ocala, Florida. According to the complaint filed with the consent decree, Franck manufactured and distributed drug products that were adulterated and misbranded in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The U.S. Department of Justice brought the action on behalf of the FDA.

from Food and Drug Administration--Press Releases http://ift.tt/1SzwxJn
via IFTTT

Simplifying Choices in the Marketplace-Standardized Plan Options and Quality Star Ratings - CMS Blog

By Kevin Counihan, CEO of HealthCare.gov & Dr. Patrick Conway, Principal Deputy Administrator of CMS

It’s hard to believe the fourth year of Open Enrollment for the Health Insurance Marketplaces is just six months away. We’re continuing to learn how to make the consumer experience even better, and have been working hard to make improvements for this year. We’ve learned about what information consumers need to make decisions and how to improve the help and support we provide throughout the enrollment process. Because shopping is so important to make sure consumers have the plan that is right for them, we are making sure consumers have clear, easy-to-understand information. We’re excited to announce some new ways we’re doing that. We want to layout two new innovations we plan to pilot with HealthCare.gov in the next year.

Simple Choice Plans

This year for the first time, consumers will have the option to select “Simple Choice plans”. These are plans that have a uniform set of features – enabling consumers to compare plans on fewer important plan factors like monthly premiums and providers in the plan’s network with the confidence of knowing that the benefits won’t vary from plan to plan.

We expect these plans will be a core part of the shopping experience on HealthCare.gov this year. To improve decision making, Simple Choice plans will display prominently in Plan Compare, with clear visual cues that show consumers the plans that are easy to compare vs. the ones that should be researched for differences.  Consumers also will be able to choose to only see these types of plans, if they want to quickly compare them.

We will make sure that consumers understand that these plans have a fixed deductible and out-of-pocket limits, and standard copayments within a metal tier (bronze, silver, gold, and platinum). And, for certain services, for instance a primary care appointment, a consumer would pay the same amount in any Simple Choice plan, regardless of the metal tier. These plans emphasize coverage of core services before the consumer has reached their deductible.

We are testing with consumers display options and descriptions for these plans, so that consumers can best understand what they offer, a clear, easy-to-understand choice. Importantly, our approach does not stifle innovation so health plans can continue to offer all kinds of benefit options that will also be easy for consumers to find.

Many of our other HealthCare.gov consumer tools, such as the physician and prescription drug lookup, as well as the quality ratings discussed below will work together with these plans to help consumers make the most informed decisions they can. Simple Choice plans will help consumers make apples-to-apples cost-sharing comparisons as they shop, enabling them to choose plans with features they find valuable, such as particular providers or a plan’s experience managing chronic conditions.

Quality Ratings

In 2014, we began development of the Quality Rating System (QRS) to provide comparable and useful information to consumers about health plans offered through the Marketplace. The information provided through the rating system can inform consumers about the quality of health care services and enrollee experience, as well as assess the overall patient and consumer experience, for health plans offered on the Marketplaces.

We designed the star rating system with input from health care quality experts and other interested parties to inform the consumer-decision making process. Star ratings provide health plan quality information on important topics, such as how well physicians coordinate with enrollees and other physicians to provide the best care, whether the plan’s network providers give members health care that achieves the best results, and how other enrollees rate their doctors and the care they receive.

In the 2017 Open Enrollment period, CMS will pilot the display of star ratings using a 5-star rating scale. The pilot will be in several selected states that use the HealthCare.gov platform. During this period, we’ll continue testing consumer use and experience and improve the display of quality rating information. We also have provided the opportunity for state-based Marketplaces to choose to display quality rating information on their websites in the 2017 Open Enrollment period.

The pilot will include plans in Michigan, Ohio, Pennsylvania, Virginia, and Wisconsin — states that CMS selected because they have a large number of health plans participating. As with all quality ratings, they simplify a lot of information and in some cases, consumers would be wise to go beyond what they see here. Piloting the display of QRS star ratings will provide CMS with key feedback to inform the best way to provide quality rating information to consumers nationwide.

The introduction of Simple Choice plans and quality star ratings are just a few new features that will give consumers the information they may need to find a plan that is right for them and their families. We will continue to listen and learn as we get nearer to the next Open Enrollment period.

 


Filed under: Uncategorized

from The CMS Blog http://ift.tt/1O0JGWo
via IFTTT

Bakery Express of Central FL., Inc. Issues Alleregy Alert on Undeclared Peanuts in 7-Eleven Fresh to Go Cookies - FDA Safety Alerts & Drug Recalls

Bakery Express of Central FL., Inc of Orlando, Florida is recalling select 7-ELEVEN FRESH TO GO cookies, because they may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1VXPXKt
via IFTTT

FDA approves first generic Crestor - FDA Press Releases

The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses

from Food and Drug Administration--Press Releases http://ift.tt/1r2FjFc
via IFTTT

Thursday, April 28, 2016

World's Choice Products, Inc. Issues Allergy Alert on Undeclared Milk And Soy Lecithin From Whey Protein in “Supreme Elixir”, “Kids Juice” And “Xtreme Fiber Detox” - FDA Safety Alerts & Drug Recalls

World's Choice Products, Inc. of San Diego, CA, is recalling the following products: 32 fluid ounce Supreme Elixir drink, 32 fluid ounce Kid's Juice, 1 pound and 8 ounce Xtreme Fiber Detox. The recall was initiated because the products contain undeclared whey protein, which contains the allergens of milk and soy lecithin.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1qZmGSF
via IFTTT

Southeastern Grocers Issues Voluntary Recall on Undeclared Peanuts in Bakery Creme Cakes - FDA Safety Alerts & Drug Recalls

Southeastern Grocers, the parent company of BI-LO, Harveys and Winn-Dixie stores, is voluntarily recalling its 32 ounce Bakery Creme Cakes and 14 ounce Bakery Sliced Creme Cakes, because the products may contain undeclared peanuts.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/239v3Y2
via IFTTT

Old Home Kitchens Issues Allergy Alert and Voluntary Recall on Undeclared Peanuts in "Old Home Kitchens 14oz Sliced Creme Cake" - FDA Safety Alerts & Drug Recalls

Old Home Kitchens is voluntarily recalling "Old Home Kitchens 14oz. Sliced Lemon Creme Cake production code 16104" "Old Home Kitchens 14oz. Sliced Vanilla Creme Cake production code 16104," and "Old Home Kitchens 14oz. Sliced Strawberry Swirl Creme Cake with a production code of 16098" ink jet coded on plastic clam shell package, due to a potential presence of peanut allergen in a CSM Bakery Solutions supplied ingredient. People who have allergy or sensitivity to peanuts run the risk of serious or life threatening allergic reaction if they consume these products.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1Sv9ob9
via IFTTT

Bakery Express of Southern California Issues Allergy Alert on Undeclared Peanut in 7-Eleven Fresh To Go Cookies - FDA Safety Alerts & Drug Recalls

Bakery Express of Southern California of Fullerton, CA is recalling 7-ELEVEN FRESH TO GO brand cookies, because it may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1Sv5KOz
via IFTTT

Wednesday, April 27, 2016

Moving toward improved care through information - CMS Blog

By: Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services
Dr. Karen DeSalvo, National Coordinator, Office of the National Coordinator for Health IT

Seven years ago, Congress passed a law to spur the country to digitize the health care experience for Americans and connect doctors’ practices and hospitals, thereby modernizing patient care through the Electronic Health Records (EHRs) Incentive Programs, also known as “Meaningful Use.” Before this shift began, many providers did not have the capital to invest in health information technology and patient information was siloed in paper records. Since then, we have made incredible progress, with nearly all hospitals and three-quarters of doctors using EHRs. Through the use of health information technology, we are seeing some of the benefits from early applications like safe and accurate prescriptions sent electronically to pharmacies and lab results available from home. But, as many doctors and patients will tell you (and have told us), we remain a long way from fully realizing the potential of these important tools to improve care and health.

That is why, as we mentioned earlier this year, we have conducted a review of the Meaningful Use Program for Medicare physicians as part of our implementation of the Medicare Access and CHIP Reauthorization Act (MACRA), with the aim of reconsidering the program so we could move closer to achieving the full potential health IT offers.

Over the last several months, we have made an unprecedented commitment to listening to and learning from physicians and patients about their experience with health information technology – both the positive and negative. We spoke with over 6,000 stakeholders across the country, including clinicians and patients, in a variety of local communities. Today, based on that feedback, we are proposing to incorporate the program in to the Merit-based Payment System (MIPS) in a way that makes it more patient-centricpractice-driven and focused on connectivity. This new program within MIPS is named Advancing Care Information.

What We’ve Learned

In our extensive sessions and workshops with stakeholders, a near-universal vision of health information technology surfaced: Physicians, patients, and other clinicians collaborating on patient care by sharing and building on relevant information.

Three central priorities to address moving forward:

  1. Improved interoperability and the ability of physicians and patients to easily move and receive information from other physician’s systems;
  2. Increased flexibility in the Meaningful Use program; and
  3. User-friendly technology designed around how a physician works and interacts with patients.

This feedback created a blueprint for how we go forward to replace the Meaningful Use program for Medicare physicians with a more flexible, outcome-oriented and less burdensome proposal.

How We’re Moving Forward

Our goal with Advancing Care Information is to support the vision of a simpler, more connected, less burdensome technology. Compared to the existing Medicare Meaningful Use program for physicians, the new approach increases flexibility, reduces burden, and improves patient outcomes because it would:

  • Allow physicians and other clinicians to choose to select the measures that reflect how technology best suits their day-to-day practice
  • Simplify the process for achievement and provide multiple paths for success
  • Align with the Office of the National Coordinator for Health Information Technology’s 2015 Edition Health IT Certification Criteria
  • Emphasize interoperability, information exchange, and security measures and require patients to access to their health information through of APIs
  • Simplify reporting by no longer requiring all-or-nothing EHR measurement or quality reporting
  • Reduce reporting to a single public health immunization registry
  • Reduce the number of measures to an all-time low of 11 measures, down from 18 measures, and no longer require reporting on the Clinical Decision Support and the Computerized Provider Order Entry measures
  • Exempt certain physicians from reporting when EHR technology is less applicable to their practice and allow physicians to report as a group

A full list of the operational differences included in this new proposal is available here, along with more details on how it would work.

These improvements should increase providers’ ability to use technology in ways that are more relevant to their needs and the needs of their patients. Previously established requirements for APIs in the newly certified technology will open up the physician desktop to allow apps, analytic tools, and medical devices to plug and play. Through this new direction, we look forward to developers and entrepreneurs taking the opportunity to design around the everyday needs of users, rather than designing a one-size-fits-all approach. Already, developers that provide over 90 percent of electronic health records used by U.S. hospitals have made public commitments to make it easier for individuals to access their own data; not block information; and speak the same language. CMS and ONC will continue to use our authorities to eliminate barriers to interoperability.

Under the new law, Advancing Care Information would affect only Medicare payments to physician offices, not Medicare hospitals or Medicaid programs. We are already meeting with hospitals to discuss potential opportunities to align the programs to best serve clinicians and patients, and will be engaging with Medicaid stakeholders as well.

This proposal, if finalized, would replace the current Meaningful Use program and reporting would begin January 1, 2017, along with the other components of the Quality Payment Program. Over the next 60 days, the proposal will be available for public comment. It is summarized here (link) and the full text is available here (link). We will continually revise and improve the program as we gather feedback from patients and physicians providing and receiving care under the Advancing Care Information category – and the Quality Payment Program as a whole. We look forward to hearing from you and working together to continue making progress in the coming months and years.


Filed under: Uncategorized

from The CMS Blog http://ift.tt/1St4n2J
via IFTTT

Schaffner Distributing Pronutri LLC. Issues an Allergy Alert on Undeclared Soy Lecithin and Milk in Re-VITA-lize - FDA Safety Alerts & Drug Recalls

Schaffner Distributing Pronutri LLC. is recalling Re-VITA-lize LOT #15554, because it contains undeclared SOY Lecithin and MILK ingredient. People who have an allergy or severe sensitivity to SOY OR MILK ingredients may run the risk of serious or life-threatening allergic reaction if they consume these products.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1VVORyL
via IFTTT

Analysis of a Social Work–Based Model of Transitional Care to Reduce Hospital Readmissions: Preliminary Data - American Geriatric Society

Efforts to reduce readmissions after hospital discharge are increasingly being made to better identify and address social and logistical needs in addition to attending to posthospital clinical challenges. A transitional care model based in the social work professional skill set may be well matched to assess and address social and logistical needs during the posthospital transitional care period. The effect of a social work–based transitional care intervention on all-cause 30-day readmission rates for Medicare fee-for-service (FFS) beneficiaries discharged from an urban medical center was analyzed. Analyses revealed a 20% relative reduction in readmissions for 1,546 Medicare FFS discharges to home, with or without home care (a 4.5% absolute rate reduction). This model may be of interest to entities that are accountable for the care of individuals with complex social needs, such as dually eligible individuals (those eligible for Medicare and Medicaid) and adults who are newly eligible for Medicaid coverage.



from Journal of the American Geriatrics Society http://ift.tt/1Uh9PXN
via IFTTT

The Natural History of Changes in Preferences for Life-Sustaining Treatments and Implications for Inpatient Mortality in Younger and Older Hospitalized Adults - American Geriatric Society

Objectives

To compare changes in preferences for life-sustaining treatments (LSTs) and subsequent mortality of younger and older inpatients.

Design

Retrospective cohort study.

Setting

Kaiser Permanente Northern California (KPNC).

Participants

Individuals hospitalized at 21 KPNC hospitals between 2008 and 2012 (N = 227,525).

Measurements

Participants were divided according to age (<65, 65–84, ≥85). The effect of age on adding new and reversing prior LST limitations was evaluated. Survival to inpatient discharge was compared according to age group after adding new LST limitations.

Results

At admission, 18,254 (54.2%) of those aged 85 and older, 18,349 (20.8%) of those aged 65 to 84, and 3,258 (3.1%) of those younger than 65 had requested that the use of LST be limited. Of the 187,664 participants who initially did not request limitations on the use of LST, 15,932 (8.5%) had new LST limitations added; of the 39,861 admitted with LST limitations, 3,017 (7.6%) had these reversed. New limitations were more likely to be seen in older participants (aged 65–84, odds ratio (OR) = 2.27, 95% confidence interval (CI) = 2.16–2.39; aged ≥85, OR = 6.43, 95% CI = 6.05–6.84), and reversals of prior limitations were less likely to be seen in older individuals (aged 65–84, OR = 0.73, 95% CI = 0.65–0.83; aged ≥85, OR = 0.46, 95% CI = 0.41–0.53) than in those younger than 65. Survival rates to inpatient discharge were 71.7% of subjects aged 85 and older who added new limitations, 57.2% of those aged 65 to 84, and 43.4% of those younger than 65 (P < .001).

Conclusion

Changes in preferences for LSTs were common in hospitalized individuals. Age was an important determinant of likelihood of adding new or reversing prior LST limitations. Of subjects who added LST limitations, those who were older were more likely than those who were younger to survive to hospital discharge.



from Journal of the American Geriatrics Society http://ift.tt/24jVLzF
via IFTTT

Intranasal application of polyethyleneimine suppresses influenza virus infection in mice

Intranasal application of polyethyleneimine suppresses influenza virus infection in mice

Emerging Microbes & Infections 5, e41 (April 2016). doi:10.1038/emi.2016.64

Authors: Biao He, Yuhong Fu, Shuai Xia, Fei Yu, Qian Wang, Lu Lu & Shibo Jiang



from Emerging Microbes & Infections http://ift.tt/1SJrt3U
via IFTTT

Amos B Smith, III: chemist, collaborator and mentor - Journal of Antibiotics

Amos B Smith, III: chemist, collaborator and mentor

The Journal of Antibiotics 69, 189 (April 2016). doi:10.1038/ja.2016.1

Author: John L Wood



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1Td5Zdi
via IFTTT

Professor Amos B Smith, III - Journal of Antibiotics

Professor Amos B Smith, III

The Journal of Antibiotics 69, 190 (April 2016). doi:10.1038/ja.2016.31

Author: Toshiaki Sunazuka



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1Td5Zdf
via IFTTT

The first total synthesis and the second- or third-generation approach - Journal of Antibiotics

The first total synthesis and the second- or third-generation approach

The Journal of Antibiotics 69, 191 (April 2016). doi:10.1038/ja.2016.30

Author: Keiichi Ajito



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1Td5Zda
via IFTTT

Organic synthesis in the Smith Group: a personal selection of a dozen lessons learned at the University of Pennsylvania - Journal of Antibiotics

Organic synthesis in the Smith Group: a personal selection of a dozen lessons learned at the University of Pennsylvania

The Journal of Antibiotics 69, 192 (April 2016). doi:10.1038/ja.2016.21

Author: Kevin P C Minbiole



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1QKz524
via IFTTT

Strategies for construction of the all-carbon macrocyclic skeleton of the ansamycin antibiotic—kendomycin - Journal of Antibiotics

Strategies for construction of the all-carbon macrocyclic skeleton of the ansamycin antibiotic—kendomycin

The Journal of Antibiotics 69, 203 (April 2016). doi:10.1038/ja.2016.5

Authors: Shu Xu & Hirokazu Arimoto



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1Sfl2Yz
via IFTTT

The Petasis-Ferrier rearrangement: developments and applications - Journal of Antibiotics

The Petasis-Ferrier rearrangement: developments and applications

The Journal of Antibiotics 69, 213 (April 2016). doi:10.1038/ja.2015.136

Authors: Emily C Minbiole & Kevin P C Minbiole



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1mFbUyO
via IFTTT

Synthesis of the phorboxazoles—potent, architecturally novel marine natural products - Journal of Antibiotics

Synthesis of the phorboxazoles—potent, architecturally novel marine natural products

The Journal of Antibiotics 69, 220 (April 2016). doi:10.1038/ja.2016.8

Authors: Zachary Shultz & James W Leahy



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1nvBWV2
via IFTTT

Total syntheses of codonopsinine and 4-epi-codonopsinine via gold-mediated tandem-catalyzed pyrrole synthesis - Journal of Antibiotics

Total syntheses of codonopsinine and 4-epi-codonopsinine via gold-mediated tandem-catalyzed pyrrole synthesis

The Journal of Antibiotics 69, 253 (April 2016). doi:10.1038/ja.2016.13

Authors: Minami Yamaguchi, Daichi Itagaki, Hirofumi Ueda & Hidetoshi Tokuyama



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1SRM5tA
via IFTTT

Synthesis of the ABCDEF and FGHI ring system of yessotoxin and adriatoxin - Journal of Antibiotics

Synthesis of the ABCDEF and FGHI ring system of yessotoxin and adriatoxin

The Journal of Antibiotics 69, 259 (April 2016). doi:10.1038/ja.2016.18

Authors: Yuan Zhang & Jon D Rainier



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1nvC3QJ
via IFTTT

Practical synthesis of the C-ring precursor of paclitaxel from 3-methoxytoluene - Journal of Antibiotics

Practical synthesis of the C-ring precursor of paclitaxel from 3-methoxytoluene

The Journal of Antibiotics 69, 273 (April 2016). doi:10.1038/ja.2016.6

Authors: Keisuke Fukaya, Yu Yamaguchi, Ami Watanabe, Hiroaki Yamamoto, Tomoya Sugai, Takeshi Sugai, Takaaki Sato & Noritaka Chida



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1Sfl0zM
via IFTTT

Total synthesis of ent-(+)-cinanthrenol A - Journal of Antibiotics

Total synthesis of ent-(+)-cinanthrenol A

The Journal of Antibiotics 69, 280 (April 2016). doi:10.1038/ja.2015.114

Authors: Liangyu Zhu & Rongbiao Tong



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1SHTxUn
via IFTTT

Synthesis and structure–activity relationship study of FD-891: importance of the side chain and C8–C9 epoxide for cytotoxic activity against cancer cells - Journal of Antibiotics

Synthesis and structure–activity relationship study of FD-891: importance of the side chain and C8–C9 epoxide for cytotoxic activity against cancer cells

The Journal of Antibiotics 69, 287 (April 2016). doi:10.1038/ja.2015.148

Authors: Tomohiro Itagaki, Ayano Kawamata, Miho Takeuchi, Keisuke Hamada, Yoshiharu Iwabuchi, Tadashi Eguchi, Fumitaka Kudo, Takeo Usui & Naoki Kanoh



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1OOvdiQ
via IFTTT

Stereoselective access to tubuphenylalanine and tubuvaline: improved Mn-mediated radical additions and assembly of a tubulysin tetrapeptide analog - Journal of Antibiotics

Stereoselective access to tubuphenylalanine and tubuvaline: improved Mn-mediated radical additions and assembly of a tubulysin tetrapeptide analog

The Journal of Antibiotics 69, 294 (April 2016). doi:10.1038/ja.2016.7

Authors: Gregory K Friestad, Koushik Banerjee, Jean-Charles Marié, Umesh Mali & Lei Yao



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1onN1IL
via IFTTT

Syntheses of methylated catechins and theaflavins using 2-nitrobenzenesulfonyl group to protect and deactivate phenol - Journal of Antibiotics

Syntheses of methylated catechins and theaflavins using 2-nitrobenzenesulfonyl group to protect and deactivate phenol

The Journal of Antibiotics 69, 299 (April 2016). doi:10.1038/ja.2016.14

Authors: Tomohiro Asakawa, Yusuke Kawabe, Atsushi Yoshida, Yoshiyuki Aihara, Tamiko Manabe, Yoshitsugu Hirose, Asuka Sakurada, Makoto Inai, Yoshitaka Hamashima, Takumi Furuta, Toshiyuki Wakimoto & Toshiyuki Kan



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1VDBMqC
via IFTTT

Proline-based phosphoramidite reagents for the reductive ligation of S-nitrosothiols - Journal of Antibiotics

Proline-based phosphoramidite reagents for the reductive ligation of S-nitrosothiols

The Journal of Antibiotics 69, 313 (April 2016). doi:10.1038/ja.2015.144

Authors: Chung-Min Park, Tyler D Biggs & Ming Xian



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1PapC3l
via IFTTT

Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model - Journal of Antibiotics

Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model

The Journal of Antibiotics 69, 319 (April 2016). doi:10.1038/ja.2015.91

Authors: Akihiro Sugawara, Hideaki Shima, Akito Sueki, Tomoyasu Hirose, Hidehito Matsui, Hayato Nakano, Hideaki Hanaki, Kiyoko S Akagawa, Satoshi Ōmura & Toshiaki Sunazuka



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1M0XZsg
via IFTTT

The use of fluorescently-tagged apoptolidins in cellular uptake and response studies - Journal of Antibiotics

The use of fluorescently-tagged apoptolidins in cellular uptake and response studies

The Journal of Antibiotics 69, 327 (April 2016). doi:10.1038/ja.2016.22

Authors: Katherine M Chong, Nalin Leelatian, Sean M Deguire, Asa A Brockman, David Earl, Rebecca A Ihrie, Jonathan M Irish, Brian O Bachmann & Gary A Sulikowski



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1nvC1bz
via IFTTT

Synthetic studies toward citrinadin A: construction of the pentacyclic core - Journal of Antibiotics

Synthetic studies toward citrinadin A: construction of the pentacyclic core

The Journal of Antibiotics 69, 331 (April 2016). doi:10.1038/ja.2016.25

Authors: Monica E McCallum, Genessa M Smith, Takanori Matsumaru, Ke Kong, John A Enquist Jr & John L Wood



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1nvBZR0
via IFTTT

The enantioselective synthesis and biological evaluation of chimeric promysalin analogs facilitated by diverted total synthesis - Journal of Antibiotics

The enantioselective synthesis and biological evaluation of chimeric promysalin analogs facilitated by diverted total synthesis

The Journal of Antibiotics 69, 337 (April 2016). doi:10.1038/ja.2016.4

Authors: Kyle W Knouse & William M Wuest



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1Sfl0zO
via IFTTT

Furan-iminium cation cyclization (FIC) in a total synthesis of manzamine alkaloids - Journal of Antibiotics

Furan-iminium cation cyclization (FIC) in a total synthesis of manzamine alkaloids

The Journal of Antibiotics 69, 340 (April 2016). doi:10.1038/ja.2016.24

Authors: Kazuyuki Tokumaru, Toshiyuki Ohfusa, Shigeru Arai & Atsushi Nishida



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1nvC2vX
via IFTTT

Natural product-derived quaternary ammonium compounds with potent antimicrobial activity - Journal of Antibiotics

Natural product-derived quaternary ammonium compounds with potent antimicrobial activity

The Journal of Antibiotics 69, 344 (April 2016). doi:10.1038/ja.2015.107

Authors: Maureen D Joyce, Megan C Jennings, Celina N Santiago, Madison H Fletcher, William M Wuest & Kevin PC Minbiole



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1LlaZb9
via IFTTT

Anti-obesity activities of the yoshinone A and the related marine γ-pyrone compounds - Journal of Antibiotics

Anti-obesity activities of the yoshinone A and the related marine γ-pyrone compounds

The Journal of Antibiotics 69, 348 (April 2016). doi:10.1038/ja.2016.19

Authors: Tomoyuki Koyama, Yoshinori Kawazoe, Arihiro Iwasaki, Osamu Ohno, Kiyotake Suenaga & Daisuke Uemura



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1QKz528
via IFTTT

Tuesday, April 26, 2016

Glenn Wayne Wholesale Bakery Issues Allergy Alert on Undeclared Peanuts in Select 7-Eleven Fresh To Go Cookies - FDA Safety Alerts & Drug Recalls

Glenn Wayne Wholesale Bakery of Bohemia, NY, is recalling select 7-ELEVEN FRESH TO GO brand cookies because they may contain undeclared peanuts. People who have an allergy to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1pCPvTX
via IFTTT

Fresenius Kabi Issues Voluntary Nationwide Recall of Sensorcaine® -MPF (bupivacaine HCl) Injection, USP due to the Presence of Particulate Matter Characterized as Glass - FDA Safety Alerts & Drug Recalls

Fresenius Kabi USA announced today it is voluntarily recalling a single lot (Lot Number 6111504; Product Code 470237) of Sensorcaine-MPF (bupivacaine HCl) Injection, USP, 0.75%, 7.5 mg/mL, 30 mL fill in a 30 mL vial. The recall is being performed to the user level due to visible particulate matter characterized as glass observed by the company during inspection of reserve samples.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1SyCrqW
via IFTTT

Monday, April 25, 2016

Krasnyi Oktyabr USA Inc. Recalls Vobla (Roach) Dry Eviscerated Salted Fish and Bream Dry Eviscerated Salted Fish Due to Possible Health Risk - FDA Safety Alerts & Drug Recalls

Krasnyi Oktyabr Inc. in Brooklyn, NY, is recalling Vobla (Roach) Dry Eviscerated Salted Fish and Bream Dry Eviscerated Salted Fish because they have the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life threatening illness or death. Consumers are warned not to use the products even if they do not look or smell spoiled.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1UdbDkk
via IFTTT

Medicaid Moving Forward - CMS Blog

By Andy Slavitt, CMS Acting Administrator and Vikki Wachino, CMS Deputy Administrator and Director for the Center for Medicaid and CHIP Services

If you haven’t been paying close attention over the last several years, you may have missed some of the major changes that have taken place in the Medicaid program.

You may know that some 72 million Americans rely on Medicaid as their source of health insurance coverage this year – 14 million more than in October 2013 thanks largely to the Affordable Care Act’s coverage expansion. For millions of children who need checkups or follow up care, pregnant women who want their babies to get a healthy start in life, adults who need health coverage when they unexpectedly lose a job, or people with disabilities who want to live independently in their communities, Medicaid has been there over the last 50 years to provide comprehensive health coverage to millions low-income American families.

But a lot has happened to health insurance coverage through Medicaid over the past several years as millions more people have gained coverage because of the Affordable Care Act: The federal government and the states have sought to strengthen the program’s focus on the consumer, the delivery of high quality care, and providing greater access points, and on developing a modern set of rules.

Today, we’re taking a next step in that work today by finalizing a long-anticipated rule that updates how Medicaid works for the nearly two-thirds of beneficiaries who get coverage through private managed care plans. These improvements modernize the way these managed care health plans operate so that Medicaid and CHIP continue to provide cost-effective, high quality care to consumers. The rule strengthens states’ efforts to support delivery system reform and authorizes the first-ever Medicaid and CHIP quality rating system so that states can publicly report plan quality information, and people can use that information to select plans. It also deploys 21st century tools to improve beneficiary communications, like electronic notices to beneficiaries and creating online provider directories. It better aligns key rules and practices with those of Marketplace and Medicare Advantage, including the addition of reporting medical loss ratio to Medicaid to ensure managed care plans focus on delivering care, not profits. And the rule also helps strengthen and improve the delivery of health care to low-income children served by the Children’s Health Insurance Program (CHIP).

But before you look at a summary of these rules, it’s worth catching you up on other major developments in Medicaid that affect every aspect of the consumer’s experience–from enrolling, to accessing high quality care, to the availability of home and community-based services.

  1. A modern enrollment experience. Applying and enrolling in Medicaid coverage is now easier than it once was and similar to the processes for applying for other health insurance programs. Enrolling into Medicaid was once very complicated, involving lots of paperwork, long waits and in-person interviews. Now, most people apply on line, by phone, or at a location convenient for them. More convenient, one-stop enrollment is possible in part thanks to sophisticated technology pursuant to the Affordable Care Act that allows enrollee information to be verified electronically – and without paper documentation. In some states, as many as 50 percent of individuals now enroll through these automated processes.
  2. Access to high quality physicians and other care providers. Access to quality health servicesis always a central focus of CMS, which was strengthened through new policies recently that seek to ensure access to care. Today’s rules take additional steps that will more tightly align payment with better, more cost-effective care. And new rules create real accountability to ensure access to care is sufficient in key specialties. Thanks in part to the work that CMS and states have done to make sure people have access to health services, adults with Medicaid coverage are just as likely to obtain primary care services as  those with private insurance, while experiencing less difficulty paying their medical bills than others. And, people with Medicaid coverage report very high satisfaction, even higher than those who get health insurance through their place of employment.
  3. Quality care to strengthen health outcomes. Medicaid is also transforming the delivery of care. States are making gains in using population based payments, episodes of care, and quality-based payments. In addition, states operate 30 health home programs that focus on coordinating care for people with chronic conditions like obesity, diabetes and mental health conditions. Over the last several years, sates have undertaken significant efforts through State Innovation Models, integrated care models, and delivery system reform incentive programs to create alignment with physicians and hospitals to provide the highest quality of care. And we have proven that when we and states dedicate ourselves to changing the delivery of care, we get results. Consider the role Medicaid has played in supporting seniors and people with disabilities to receive care in their communities. Twenty years ago, more than 80 percent of Medicaid spending on long-term services was on institutional care. Now, thanks to CMS’ and states’ work to make more options available, community-based care has significantly increased. Medicaid has also partnered with several national organizations at the provider, consumer and state levels to help us think through ways to improve both the delivery and quality of care Medicaid and CHIP provides, such as the March of Dimes, the Medicaid State Dental Association and seven academic Centers of Excellence.
  4. A platform for innovation. Medicaid innovates more quickly when states have the tools to respond to the needs of their residents. To help support these delivery system reforms through improvements to the coordination of patient care, states, with the support of CMS, are working to update legacy IT systems to ones that leverage proven IT methods. This is key in helping to deploy tools, such as electronic health records, that improve the coordination of patient care, further supporting innovative efforts that lead to smarter spending and healthier people.

Most importantly, Medicaid is there when you need it, for working class families, working Americans, people falling on temporary hard times, or living with a disability. Take Todd, a full time student with two part time jobs in Utah who was recently profiled by the Kaiser Family Foundation. He and his wife, Erin, were uninsured but had a new baby. They learned that Erin and their baby Jane were eligible for Medicaid. “When we found out that my wife and Jane would be covered, it definitely felt like a burden lifted a weight off our shoulders,” Todd said. “We don’t make enough to really take care of ourselves the way we would like to.”

It’s because of people like Todd and Erin and people like you that we have invested so heavily and thoughtfully in Medicaid and put forward the rules we have today, which will also support physicians and hospitals and states in improving service, quality and health for millions of Americans.

###


Filed under: Uncategorized

from The CMS Blog http://ift.tt/1rv9iGI
via IFTTT

Pursuing Health Equity for the Nation - CMS Blog

By: Cara V. James, Ph.D., Director of the Office of Minority Health at the Centers for Medicare & Medicaid Services
Romana Hasnain-Wynia, M.S., Ph.D., Program Director for Addressing Disparities at the Patient-Centered Outcomes Research Institute (PCORI)  

‘Accelerating Health Equity for the Nation’ is this year’s theme for National Minority Health Month, which we mark every April as a time to focus on efforts to help all Americans achieve the highest level of health they can. Health equity is a challenging goal given how many factors contribute to optimal health, but it is a goal we can never stop striving to attain. There are numerous barriers minorities and other underserved populations face in accessing the health care and those barriers often lead to disparities in health and healthcare outcomes. The Centers for Medicare & Medicaid Services Office of Minority Health and the Patient-Centered Outcomes Research Institute (PCORI) are two of the organizations established by the ACA working to address these barriers and accelerate progress toward health equity.

The CMS Office of Minority Health is dedicated to increasing understanding and awareness of health disparities among CMS beneficiaries and ensuring that the voices and needs of minority and underserved populations are included in developing, implementing, and evaluating CMS programs and policies. It does this through its “USA” framework, which has three interconnected elements that together will help lead to health equity —increasing Understanding and awareness of disparities among its beneficiaries; creating and sharing Solutions; and accelerating the implementation of effective Actions. Key activities include strengthening CMS data and using it to create initiatives that organizations can use to reduce disparities, through such specific efforts as the CMS Equity Plan to Improve Quality in Medicare, the Mapping Medicare Disparities Tool, and From Coverage to Care.

PCORI’s mandate is to improve the quality and relevance of evidence available to help a range of healthcare stakeholders—including patients, caregivers, clinicians, employers, insurers, and policy makers—make better-informed health decisions. It does this by funding research that compares two or more approaches to care to determine what works best, for whom, under which circumstances, based on the outcomes most important to patients.

PCORI’s authorizing legislation directs it to pay particular attention to health disparities and to include members of minority groups in research whenever possible. That’s one reason why Addressing Disparities is one of PCORI’s five National Priorities for Research, which govern how PCORI awards its research dollars. The Addressing Disparities program now includes a substantial portfolio of studies designed to determine how to reduce barriers to effective preventive, diagnostic, or therapeutic care, taking into account individual and group preferences, to achieve the best outcomes in each population.

Seeking New Approaches

Both the CMS Office of Minority Health and PCORI also are concerned with strengthening the healthcare workforce to better serve vulnerable and underserved patient populations. This includes initiatives focusing on how to better make use of lay members of healthcare teams—who are known, for example, as community health workers, patient navigators, and promotores de salud—as links between patients, communities, and the healthcare system.

CMS Office of Minority Health is working on how to support, engage, and empower these professionals, while PCORI has funded more than 50 projects that are comparing health outcomes and other aspects of programs that do and don’t include lay members of healthcare teams. One large study involving 30 primary care clinics and almost 1,900 patients compares the effectiveness of a clinic-based standard of care to a collaborative approach that includes community health workers. It asks whether the collaborative approach improves hypertension control for racial and ethnic minorities and other groups that experience disparities in this condition. 

Delivering Health Information and Services via Telecommunications

Telehealth is another area that both CMS and PCORI are exploring as a means to reduce disparities.

PCORI is currently funding 26 projects on telehealth, many of which focus on underserved populations. One of these studies compares the effectiveness of a telehealth self-management approach versus traditional in-person care for African-American and Hispanic/Latino patients with chronic heart failure. In the telehealth intervention, a care provider contacts the patient weekly via a video call. The study will measure emergency room use, quality of life, and other outcomes. Another CMS initiative is looking for ways to expand the use of telehealth in rural areas, where health care tends to be less available than elsewhere.

Reducing Disparities in Chronic Disease Treatment and Outcomes

Both the CMS Office of Minority Health and PCORI have a commitment to reducing disparities in the treatment of a range of illnesses. Among these is asthma, which is more prevalent and severe among African Americans and Hispanics/Latinos than among whites, as are a range of disparities in health outcomes.

At PCORI, there are more than a dozen projects addressing racial and ethnic disparities in asthma treatment outcomes. These include eight studies that compare ways to increase patient and clinician adherence to the National Asthma Education and Prevention Program guidelines. Project teams include patients, clinicians, insurers, health systems, community clinics and practices, public health departments, and patient and caregiver advocacy organizations.

Accelerating Health Equity

The CMS Office of Minority Health and PCORI are just two of many organizations working to move our nation further along the path to health equity.  However, to achieve that goal, we need more individuals, organizations, and communities to join the effort. We look forward to working with you to make health equity a reality.


Filed under: Uncategorized

from The CMS Blog http://ift.tt/1T0iU1N
via IFTTT

CSM Bakery Solutions Issues Allergy Alert on Undeclared Peanut in Chick-Fil-A Chocolate Chunk Cookies - FDA Safety Alerts & Drug Recalls

CSM Bakery Solutions is voluntarily recalling Chick-fil-A Chocolate Chunk Cookies because they may contain low levels of undeclared peanut. People who have an allergy or severe sensitivity to peanut run the risk of a serious or life-threatening allergic reaction if they consume these products.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/23Vo8r7
via IFTTT

Sunday, April 24, 2016

CVS Pharmacy Announces Voluntary Recall of Gold Emblem Abound Organic Spiced Herbal Tea Due to Possible Health Risk - FDA Safety Alerts & Drug Recalls

CVS Pharmacy® announced today that it has voluntarily recalled select cases of Gold Emblem Abound™ Organic Spiced Herbal Tea following notification from the manufacturer that the product is potentially contaminated with Salmonella. An ingredient produced by the manufacturer’s raw material supplier tested positive for Salmonella in another company’s product. CVS Pharmacy’s Gold Emblem product also contains this ingredient.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1rsHouV
via IFTTT

Saturday, April 23, 2016

CRF Frozen Foods Recalls Frozen Vegetables Due to Possible Health Risk - FDA Safety Alerts & Drug Recalls

CRF Frozen Foods of Pasco, Washington is voluntarily recalling fifteen frozen vegetable items that have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, listeria infection can cause miscarriages and stillbirths among pregnant women.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1MOX05t
via IFTTT

Friday, April 22, 2016

Index - Geriatrics

Note: Page numbers of article titles are in boldface type.

from Clinics in Geriatric Medicine http://ift.tt/1VOhRbB
via IFTTT

Forthcoming Issue - Geriatrics

Infectious Diseases in Geriatric Medicine

from Clinics in Geriatric Medicine http://ift.tt/216DHqG
via IFTTT

Contents - Geriatrics

Cynthia Boyd, James T. Pacala and Michael W. Rich

from Clinics in Geriatric Medicine http://ift.tt/1VOhP3r
via IFTTT

Contributors - Geriatrics

CYNTHIA BOYD, MD, MPH

from Clinics in Geriatric Medicine http://ift.tt/216DFzc
via IFTTT

Copyright - Geriatrics

ELSEVIER

from Clinics in Geriatric Medicine http://ift.tt/1VOhQVe
via IFTTT

Managing Chronic Conditions in Older Adults with Cardiovascular Disease - Geriatrics

CLINICS IN GERIATRIC MEDICINE

from Clinics in Geriatric Medicine http://ift.tt/216DFz8
via IFTTT

Working Together in the Care of Patients with Cardiovascular Disease and Multimorbidity - Geriatrics

More than 70% of older adults have cardiovascular disease (CVD), and the vast majority of these have multiple coexisting conditions; indeed, more than 50% of older adults have multimorbidity (MM), defined as three or more chronic conditions. Tremendous advances in the diagnosis and treatment of CVD over the past five decades have culminated in the publication of numerous evidence-based guidelines, which have contributed to improved cardiovascular care and clinical outcomes. However, positive results from the “guideline age” have been tempered by two factors that have been increasingly recognized by cardiologists and geriatricians: (1) most patients with CVD are elderly and also have MM, increasing the likelihood that treatment of their CVD will exacerbate other chronic conditions; and (2) most guideline recommendations, based on evidence from studies with restrictive inclusion criteria or nonrepresentative enrollment, do not account for complicating effects from coexisting conditions and treatments.

from Clinics in Geriatric Medicine http://ift.tt/1VOhQV2
via IFTTT

Magnitude and Impact of Multimorbidity on Clinical Outcomes in Older Adults with Cardiovascular Disease - Geriatrics

The authors aim to synthesize the current literature on the magnitude and impact of multimorbidity on clinical outcomes in older adults with cardiovascular disease (CVD). Most studies reported a significant association between the number of morbidities and the risk of dying. Multimorbidity was assessed either by counting the number of conditions or by use of the Charlson or Elixhauser indices. There are limited data available on the magnitude and impact of multimorbidity on clinical outcomes in patients with CVD and essentially no data on universal health outcomes (eg, health-related quality of life, symptom burden, and function).

from Clinics in Geriatric Medicine http://ift.tt/216DFz2
via IFTTT

Epidemiology of Multimorbidity in Older Adults with Cardiovascular Disease - Geriatrics

Multimorbidity is the most significant condition affecting older adults, and it impacts every component of health care management and delivery. Multimorbidity significantly increases with age. For individuals with a diagnosis of cardiovascular disease, multimorbidity has a significant effect on the presentation of the disease and the diagnosis, management, and patient-centered preferences in care. Evidence-based therapeutics have focused on cardiovascular focused morbidity. Over the next 25 years, the proportion of adults aged 65 and older is estimated to increase three-fold. The needs of these patients require a fundamental shift in care from single disease practices to a more patient-centered framework.

from Clinics in Geriatric Medicine http://ift.tt/1VOhQEF
via IFTTT

Integrating Care Across Disciplines - Geriatrics

Interdisciplinary care teams are important in managing older patients. Geriatric patients with cardiovascular problems represent a unique paradigm for interdisciplinary teams, and patients benefit from the assistance of physicians, nurses, social workers, pharmacists, and therapists collaborating on treatment plans. Teams work on the inpatient and outpatient sides and at patients’ homes to maximize function and prevent readmissions to the hospital.

from Clinics in Geriatric Medicine http://ift.tt/216DFiH
via IFTTT

Multimorbidity and End of Life Care in Patients with Cardiovascular Disease - Geriatrics

The care of patients with severe cardiovascular disease and multimorbidity entails complex medical decision-making especially at the end of life. Proven therapies must be incorporated into the context of patient preferences, values, and goals to achieve effective titration of medications and appropriate initiation and withdrawal of cardiac device therapies. As patients decline in the terminal stages, it is important to modify medical and device therapies in accordance with goals and values, and with hemodynamic changes, increasing multimorbidity, and accumulating symptom burden. The provision of effective end of life care for those with cardiovascular disease and multimorbidity requires cooperation between palliative care, specialty care, and primary care.

from Clinics in Geriatric Medicine http://ift.tt/1VOhQEB
via IFTTT

Multimorbidity in Older Adults with Atrial Fibrillation - Geriatrics

Older adults with atrial fibrillation often have multiple comorbid conditions, including common geriatric syndromes. Pharmacologic therapy, whether for rate control or rhythm control, can result in complications related to polypharmacy in patients who are often on multiple medications for other conditions. Because of uncertainty about the relative risks and benefits of rate versus rhythm control (including antiarrhythmic or ablation therapy), anticoagulation, and procedural treatments (eg, ablation, left atrial appendage closure, pacemaker placement) in older patients with multimorbidity, shared decision-making is essential. However, this may be challenging in patients with cognitive dysfunction, high fall risk, or advanced comorbidity.

from Clinics in Geriatric Medicine http://ift.tt/216DHa2
via IFTTT

Delirium as a Predictor of Physical and Cognitive Function in Individuals Aged 80 and Older After Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement - American Geriatric Society

Objectives

To determine how development of delirium after surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) could predict activity of daily living (ADL) and instrumental ADLs (IADL) disability, cognitive function, and self-reported health in individuals aged 80 and older.

Design

Prospective cohort study.

Setting

Tertiary university hospital.

Participants

Individuals aged 80 and older undergoing elective SAVR or TAVI (N = 136).

Measurements

Delirium was assessed for 5 days using the Confusion Assessment Method. The Barthel Index, Nottingham Extended ADL Scale, and SF-12 were used to determine ADL and IADL ability and self-reported health at baseline and 1- and 6-month follow-up. Cognition was assessed using the Mini-Mental State Examination at baseline and 6-month follow-up.

Results

Participants had lower IADL scores 1 month after SAVR than at baseline (baseline 58, 1 month: delirium 42, no delirium 50, P ≤ .02), but scores had returned to baseline levels at 6 months. The Medical Outcomes Study 12-item Short-Form Health Survey (SF-12) Physical Component Summary (PCS) score was higher at 6-month follow-up (48) than at baseline (39), especially in participants who did not develop delirium (P < .001). No differences in other outcomes were found. Regression models suggest that delirium may help predict IADL disability 1 month after baseline (P ≤ .07) but does not predict large differences in ADL disability, cognitive function, or SF-12-scores. Individuals who underwent TAVI and developed delirium had lower ADL (baseline 19, 1-month 16, P < .001) and IADL (baseline 49, 1-month 40, P = .003) scores at 1-month follow-up. SF-12 PCS score (baseline 30) increased from baseline to 1- (35, P = .04) and 6- (35, P = .02) month follow-up in individuals who underwent TAVI and did not develop delirium. Delirium after TAVI predicted greater ADL and IADL disability at 1-month but not at 6-month follow-up.

Conclusion

Individuals who develop delirium after SAVR and TAVI have poorer short-term IADL function but do not seem to have long-term reductions in physical, mental, or self-reported health.



from Journal of the American Geriatrics Society http://ift.tt/249SWAW
via IFTTT

Nuvi Global Corporation Issues Allergy Alert on Undeclared Milk and Soy in StemVitae 30oz Liquid Multivitamin - FDA Safety Alerts & Drug Recalls

Nuvi Global Corporation of Rancho Cucamonga California is recalling StemVitae 30oz liquid multivitamin because it contains undeclared milk and soy lecithin. People who have an allergy or severe sensitivity to milk or soy run the risk of serious or life-threatening allergic reaction if they consume this product.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/1XN5QkL
via IFTTT

FDA proposes ban on electrical stimulation devices intended to treat self-injurious or aggressive behavior - FDA Press Releases

The U.S. Food and Drug Administration today announced a proposal to ban electrical stimulation devices (ESDs) used for self-injurious or aggressive behavior because they present an unreasonable and substantial risk to public health that cannot be corrected or eliminated through changes to the labeling.

from Food and Drug Administration--Press Releases http://ift.tt/1Solrn5
via IFTTT

2016 Annual Scientific Meeting - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/1TmIu48
via IFTTT

Paper Abstract - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/1r3REJE
via IFTTT

Thursday, April 21, 2016

Urgent Product Recall for Undeclared Soy and Milk Allergens - FDA Safety Alerts & Drug Recalls

MagZuma Nutrition of Tulsa Oklahoma is recalling effected lots of it’s Life’s Qik Fix™ and Zuma Supreme™ products because they contain undeclared SOY and MILK allergens. People who have an allergy or severe sensitivity to Soy or Milk allergens run the risk of serious or life-threatening allergic reaction if they consume this product. No illnesses have been reported to date and there are no other product concerns except for people that have Soy or Milk allergies.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/26hQiv2
via IFTTT

Exceptional Health Products Issues Allergy Allert On Undeclared Soy And Milk Allergens In Angel Wings™- Daily Multi 120 Capsules - FDA Safety Alerts & Drug Recalls

Exceptional Health Products of Tulsa Oklahoma is recalling Angel Wings™ - Daily Multi 120 Capsules because this product contains undeclared SOY and MILK allergens. People who have an allergy or severe sensitivity to Soy or Milk allergens run the risk of serious or life-threatening allergic reaction if they consume this product.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/245vLaT
via IFTTT

Issue InformationAbout the AGS - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/22Qp9La
via IFTTT

Issue InformationMasthead - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/1VEcsof
via IFTTT

Issue InformationOfficers of the AGS - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/22QpayE
via IFTTT

Issue InformationTOC - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/1VEcqfV
via IFTTT

Health-Related Quality of Life at Admission Is Associated with Postdischarge Mortality Functional Decline and Institutionalization in Acutely Hospitalized Older Medical Patients - American Geriatric Society

Objectives

To assess the independent association between health-related quality of life (HRQOL) at admission and mortality, functional decline, and institutionalization 3 and 12 months after admission in acutely hospitalized older adults.

Design

Post hoc analysis of data from prospective cohort study, 2006 to 2009, 12-month follow-up.

Setting

Eleven medical wards in three hospitals in the Netherlands.

Participants

Medical patients aged 65 and older acutely hospitalized for 48 hours or longer (N = 473).

Measurements

Outcomes: mortality, functional decline, and institutionalization, 3 and 12 months after admission. Main determinant was HRQOL (utility based on the EuroQol-5D at admission, reflecting the relative desirability of a particular health state and is measured on a scale from 0 (death) to 1 (full health). Some health states are regarded as being worse than death, resulting in negative utilities, with a minimum of −0.330). Participants were split into two groups based on median utility at admission. Unadjusted and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using Cox and logistic regression analyses, adjusted for sociodemographic and health variables.

Results

Median utility was 0.775 (interquartile range 0.399–0.861). Utility greater than 0.775, indicating high HRQOL, was associated with lower risk of mortality (hazard ratio = 0.38, 95% CI = 0.18–0.83) and functional decline (OR = 0.47, 95% CI = 0.28–0.79) at 3 months in the adjusted models. At 12 months, these associations were statistically significant in the crude models but not in the adjusted models. Utility was not associated with risk of institutionalization at 3 or 12 months.

Conclusion

Higher HRQOL at admission was associated with lower risk of mortality and functional decline 3 months after admission. In older, acutely hospitalized individuals, the EQ-5D may provide a means of risk stratification and may ultimately guide individuals, their families, and professionals in treatment decisions during hospitalization.



from Journal of the American Geriatrics Society http://ift.tt/22Qp9L0
via IFTTT

Trends in Prevalence and Determinants of Potentially Inappropriate Prescribing in the United States: 2007 to 2012 - American Geriatric Society

Objectives

To estimate the prevalence and determinants of the use of potentially inappropriate medications (PIMs) in older U.S. adults using the 2012 Beers criteria.

Design

Retrospective cohort study in a random national sample of Medicare beneficiaries.

Setting

Fee-for-service Medicare beneficiaries from 2007 to 2012.

Participants

U.S. population aged 65 and older with Parts A, B, and D enrollment in at least 1 month during a calendar year (N = 38,250 individuals; 1,308,116 observations).

Measurements

The 2012 Beers criteria were used to estimate the prevalence of the use of PIMs in each calendar month and over a 12-month period using data on diagnoses or conditions present in the previous 12 months. Generalized estimating equations were used to account for the dependence of multiple monthly observations of a single person when estimating 95% confidence intervals (CIs), and logistic regression was used to identify independent determinants of PIM use.

Results

The point prevalence of the use of PIMs decreased from 37.6% (95% CI = 37.0–38.1) in 2007 to 34.2% (95% CI = 33.6–34.7) in 2012, with a statistically significant 2% (95% CI = 1–3%) decline per year assuming a linear trend. The 1-year period prevalence declined from 64.9% in 2007 to 56.6% in 2012. The strongest predictor of PIM use was the number of drugs dispensed. Individuals aged 70 and older and those seen by a geriatrician were less likely to receive a PIM.

Conclusion

From 2007 to 2012, the prevalence of PIM use in older U.S. adults decreased according to the 2012 Beers criteria, although it remains high, still affecting one-third each month and more than half over 12 months. The number of dispensed prescriptions could be used to target future interventions.



from Journal of the American Geriatrics Society http://ift.tt/1VEcpZB
via IFTTT

Evaluation of the Risk of Nitrofurantoin Lung Injury and Its Efficacy in Diminished Kidney Function in Older Adults in a Large Integrated Healthcare System: A Matched Cohort Study - American Geriatric Society

Objectives

To determine the risk to older adults of lung injury associated with treatment of cystitis using nitrofurantoin and the risk of treatment failure in the presence of diminished creatinine clearance (CrCl).

Design

Retrospective, matched cohort.

Setting

Integrated healthcare system.

Participants

Individuals aged 65 and older with a diagnosis of cystitis between 2007 and 2012 who were given nitrofurantoin (N = 13,421) were matched 1:3 on age, sex, race and ethnicity, and prescription date with individuals who were given other antibiotics for cystitis.

Measurements

Conditional logistic regression determined the association between nitrofurantoin and lung injury in the matched cohort. In participants exposed to nitrofurantoin, chronic treatment was compared with acute treatment using multivariable logistic regression. Treatment failure was compared in three CrCl groups.

Results

Nitrofurantoin exposure was not statistically significantly associated with lung injury (adjusted risk ratio (aRR) = 0.90, 95% confidence interval (CI) = 0.80–1.00), but chronic nitrofurantoin therapy was associated with greater risk of lung injury than acute exposure (aRR = 1.53, 95% CI = 1.04, 2.24). Treatment failure rates did not differ according to CrCl.

Conclusion

This large, retrospective, matched-cohort study conducted in older adults supports the 2012 American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults recommendations against the use nitrofurantoin for long-term suppressive treatment of cystitis but not the recommendation against its use in poor renal function because of the risk of treatment failure.



from Journal of the American Geriatrics Society http://ift.tt/22Qpaig
via IFTTT

Frailty Screening in Low- and Middle-Income Countries: A Systematic Review - American Geriatric Society

Objectives

To conduct a systematic review of frailty screening tools used in low- and middle-income countries (LMICs).

Design

Systematic review.

Setting

LMICs, as defined by the World Bank on June 30, 2014.

Participants

Elderly adults (as defined by the authors) living in LMICs.

Measurements

Studies were included if the population under consideration lived in a LMIC, the study involved an assessment of frailty, the study population was elderly adults, and the full text of the study was available in English. The Medline, Embase, CINAHL and PsychINFO databases were searched up to June 30, 2014.

Results

Seventy studies with data from 22 LMICs were included in the review. Brazil, Mexico, and China provided data for 60 of the 70 studies (85.7%), and 15 countries contributed data to only one study. Thirty-six studies used the Fried criteria to assess frailty, 20 used a Frailty Index, and eight used the Edmonton Frailty Scale; none of the assessment tools used had been fully validated for use in a LMIC.

Conclusion

There has been a rapid increase in the number of published studies of frailty in LMICs over the last 5 years. Further validation of the assessment tools used to identify frail elderly people in LMICs is needed if they are to be efficient in identifying those most in need of health care in such settings.



from Journal of the American Geriatrics Society http://ift.tt/1VEcpZv
via IFTTT

Spousal Associations Between Frailty and Depressive Symptoms: Longitudinal Findings from the Cardiovascular Health Study - American Geriatric Society

Objectives

To determine whether older adult spouses’ frailty states and depressive symptoms are interrelated over time.

Design

Longitudinal, dyadic path analysis using the Actor–Partner Interdependence Model.

Setting

Data were from baseline (1989–90), Wave 3 (1992–93), and Wave 7 (1996–97), all waves in which frailty and depressive symptoms were measured, of the Cardiovascular Health Study (CHS), a multisite, longitudinal, observational study of risk factors for cardiovascular disease in adults aged 65 and older.

Participants

Spouses in 1,260 community-dwelling married couples.

Measurements

Frailty was measured using the CHS criteria, categorized as nonfrail, prefrail, or frail. Depressive symptoms were measured using the 10-item Center for Epidemiologic Studies Depression Scale.

Results

Within individuals (actor effects), greater frailty predicted greater subsequent depressive symptoms, and greater depressive symptoms predicted greater subsequent frailty. Between spouses (partner effects), an individual's greater frailty predicted the spouse's greater frailty, and an individual's greater depressive symptoms predicted the spouse's greater depressive symptoms.

Conclusion

Frailty and depressive symptoms are interrelated in older adult spouses. For older couples, interventions to prevent or treat frailty and depression that focus on couples may be more effective than those that focus on individuals.



from Journal of the American Geriatrics Society http://ift.tt/22Qp9ef
via IFTTT

Identification of Risk Factors for Mortality and Poor-Quality-of-Life Survival in Frail Older Women Participating in the Women's Health Initiative Observational Study - American Geriatric Society

Objectives

To identify potentially modifiable factors associated with overall and poor-quality-of-life (QoL) survival in physically frail older women.

Design

Prospective study with 7 years of follow-up to examine mortality and, in survivors with a QoL measurement within the next 3 years, to examine poor- versus good-QoL patterns of survival.

Setting

Women's Health Initiative Observational Study (WHI OS).

Participants

Frail older women (N = 11,070; average age 72.6, range 65–82).

Measurements

Frailty was defined using the modified Fried criteria. Study outcomes were overall survival and global QoL. Risk factors were measured at the first follow-up clinic visit for WHI OS participants between 1997 and 2001.

Results

Of 11,070 frail women, 1,487 (13%) died. After 2,677 survivors with poor or unknown QoL were excluded at study baseline, 3,153 (46%) reported good QoL, and 1,263 (18%) reported poor QoL at the end of study follow-up; QoL measures for 2,490 (38%) were unavailable. Older age, history of cardiovascular disease, diabetes mellitus, poor self-rated health, body mass index less than 25.0 kg/m2, waist circumference greater than 88 cm, systolic blood pressure greater than 140 mmHg, high number and severity of somatic symptoms, smoking, and low education were associated with greater likelihood of poor-QoL survival. Cumulative baseline risk scores demonstrated an approximately linear increase in probability of poor-QoL survival with an increase in risk factors. The probability of poor-QoL survival was 0.19 (95% confidence interval (CI) = 0.15–0.22) in those with zero to two risk factors and 0.40 (95% CI = 0.35–0.44) in those with six or more risk factors.

Conclusion

Several potentially important risk factors for aging well that can be monitored in clinical and research settings, some of which are modifiable, were identified in a large group of frail old women.



from Journal of the American Geriatrics Society http://ift.tt/1VEcpZq
via IFTTT

Clinician Effectiveness in Assessing Fitness to Drive of Medically At-Risk Older Adults - American Geriatric Society

Objectives

To model the relative contributions of driver data and clinical judgments to clinical ratings of driver capability for a state licensing authority and to compare ratings with on-road test results.

Design

Retrospective, logistic regression.

Setting

Missouri Driver License Bureau.

Participants

Adults aged 60 and older (N = 652; 52% male) evaluated by a physician of their choosing and a portion subsequently road tested (n = 286).

Measurements

Clinical data from an evidence-based physician statement (Form 1528). A three-level rating (likely capable, unclear, not capable) was collapsed into two outcomes (0 likely capable; 1 unclear, not capable) as the dependent variable. Independent variables (predictors) were age, sex, driving exposure, recent crash or police action, number of medical conditions, medication side effects, driver insight, and disease functional severity rating for driving.

Results

Three variables in the model (Nagelkerke coefficient of determination = 0.64; P < .001) were significant in the expected direction: disease functional severity for driving (odds ratio (OR = 6.65), insight (OR = 2.35), and age (OR = 1.06). Proportionately more drivers rated likely capable (73%) passed the road test than those rated unclear or not capable (62%).

Conclusion

Judgments of disease severity, decrements in driver insight, and older age influenced clinician ratings of driving capability. Correspondence of physician ratings to on-road test outcomes was imperfect, highlighting the complexities in translation of clinical judgments to on-road performance. Both means of assessment have important and additive roles in driver licensing.



from Journal of the American Geriatrics Society http://ift.tt/22Qpai2
via IFTTT